alexa Abstract | The Role of Psychiatric Drugs and their Minimal-Medication Alternatives in the Treatment of Schizophrenia
ISSN: 2378-5756

Journal of Psychiatry
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access

Abstract

Throughout this report I will be discussing reasons why our current psychiatric system needs improvements concerning the use of psychiatric drugs and how they may not be the answer to the symptoms of schizophrenia. This is an important topic to study considering the health dangers that patients are faced with today as a result of their illness and the medication used for it. I have researched the high success rates of alternative, minimum medication programmes, like open dialogue, which have greater focus on psychotherapies, as opposed to antipsychotic drugs. I have discussed the fundamental flaws with our accepted ideas of schizophrenia, and the implications this neurobiological research has for treatments. I have highlighted the problems with the psychiatric pharmaceutical industry, (particularly drug trials) which markets drugs in a misleading way, creating a paradigm where psychiatrists rely heavily on antipsychotics to stabilise their patients. This is not the best solution for the long term health of patients. I have concluded in this report that improvements to our system through increased integration of psychotherapies and lower dosages of psychiatric drugs, would greatly impact the quality of treatment that schizophrenic patients receive.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Megan Buoey*

Keywords

Psychiatric, Drugs, Health, Schizophrenia, Neurotransmitter, Psychiatry, Psychiatry Diseases, Schizophrenia

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords